Researchers from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine have published a study in JACC: Heart Failure that sheds light on how managing cardiovascular risk factors can influence health outcomes in carriers of the transthyretin V142I variant.
Leave A Comment